These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8653485)

  • 21. Report slams US FDA's drug safety reform efforts.
    Bristol N
    Lancet; 2007 Mar; 369(9567):1072. PubMed ID: 17405202
    [No Abstract]   [Full Text] [Related]  

  • 22. Methods and systems to detect adverse drug reactions in hospitals.
    Thürmann PA
    Drug Saf; 2001; 24(13):961-8. PubMed ID: 11735652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spontaneous reporting of adverse drug reactions in elderly patients in Sicily (Italy).
    Cutroneo P; Greco S; Cucinotta G; Arcoraci V; Caputi AP
    Pharmacol Res; 1999 Jul; 40(1):41-6. PubMed ID: 10378989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. When to report adverse drug reactions in children?
    Barton C; Hawcutt DB
    Arch Dis Child; 2015 Jul; 100(7):682-3. PubMed ID: 25854873
    [No Abstract]   [Full Text] [Related]  

  • 25. Adverse drug reactions (ADRs) in children: Part 1.
    Kanneh AB
    Paediatr Nurs; 2004; 16(6):32-5. PubMed ID: 15328727
    [No Abstract]   [Full Text] [Related]  

  • 26. Adverse drug reactions in a medical ward.
    Wu FL; Yang CC; Shen LJ; Chen CY
    J Formos Med Assoc; 1996 Mar; 95(3):241-6. PubMed ID: 8857258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A major rethink is needed on reporting adverse drug reactions.
    Herxheimer A; Vohra S; Montastruc JL; Edwards R
    BMJ; 2012 Sep; 345():e6379. PubMed ID: 23008204
    [No Abstract]   [Full Text] [Related]  

  • 28. Adverse drug reactions.
    Shuttleworth A
    Nurs Times; 2006 Jul 25-31; 102(30):58. PubMed ID: 16903313
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of pharmacy-based concurrent surveillance and medical record retrospective reporting of adverse drug reactions.
    Schumock GT; Thornton JP; Witte KW
    Am J Hosp Pharm; 1991 Sep; 48(9):1974-6. PubMed ID: 1928145
    [No Abstract]   [Full Text] [Related]  

  • 30. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
    Tandon VR; Mahajan V; Khajuria V; Gillani Z
    Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
    Jose J; Rao PG
    Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
    Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
    Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protecting the health of the public--Institute of Medicine recommendations on drug safety.
    Psaty BM; Burke SP
    N Engl J Med; 2006 Oct; 355(17):1753-5. PubMed ID: 17030843
    [No Abstract]   [Full Text] [Related]  

  • 34. Adverse drug reaction reporting among health care workers at Mulago National Referral and Teaching hospital in Uganda.
    Katusiime B; Semakula D; Lubinga SJ
    Afr Health Sci; 2015 Dec; 15(4):1308-17. PubMed ID: 26958036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thoughts on signal detection in pharmacovigilance.
    Shakir SA
    Drug Saf; 2007; 30(7):603-6. PubMed ID: 17604411
    [No Abstract]   [Full Text] [Related]  

  • 36. Adverse drug events: what's the truth?
    Dean B
    Qual Saf Health Care; 2003 Jun; 12(3):165-6. PubMed ID: 12792003
    [No Abstract]   [Full Text] [Related]  

  • 37. Semantic categories and relations for modelling adverse drug reactions towards a categorial structure for pharmacovigilance.
    Bousquet C; Trombert B; Kumar A; Rodrigues JM
    AMIA Annu Symp Proc; 2008 Nov; 2008():61-5. PubMed ID: 18998982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-drug interactions and adverse drug reactions: separating the wheat from the chaff.
    Pirmohamed M
    Wien Klin Wochenschr; 2010 Feb; 122(3-4):62-4. PubMed ID: 20213370
    [No Abstract]   [Full Text] [Related]  

  • 39. Assessing the performance characteristics of signals used by a clinical event monitor to detect adverse drug reactions in the nursing home.
    Handler SM; Hanlon JT; Perera S; Saul MI; Fridsma DB; Visweswaran S; Studenski SA; Roumani YF; Castle NG; Nace DA; Becich MJ
    AMIA Annu Symp Proc; 2008 Nov; 2008():278-82. PubMed ID: 18998853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Data-driven prediction of adverse drug reactions induced by drug-drug interactions.
    Liu R; AbdulHameed MDM; Kumar K; Yu X; Wallqvist A; Reifman J
    BMC Pharmacol Toxicol; 2017 Jun; 18(1):44. PubMed ID: 28595649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.